EQUILLIUM, INC. Common Stock, Capital Shares Reserved for Future Issuance
EQUILLIUM, INC. (EQ) had Common Stock, Capital Shares Reserved for Future Issuance of 101.30 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 101.30M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 101.48M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 80.69M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 81.48M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 101.30M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 101.48M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 80.69M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 81.48M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 17.11M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 15.33M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 13.26M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 13.39M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 13.39M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 13.56M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 9.95M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 10.09M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 10.09M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 10.24M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 8.18M shares 10-K · filed 2024-03-25 |
| 2022-09-30 | 8.24M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 8.24M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 8.32M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 6.55M shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 6.62M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 6.62M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 6.97M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 4.20M shares 10-K · filed 2022-03-23 |
| 2020-09-30 | 4.22M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 4.22M shares 10-Q · filed 2020-08-12 |
| 2020-03-31 | 4.26M shares 10-Q · filed 2020-05-13 |
| 2019-12-31 | 3.22M shares 10-K · filed 2021-03-24 |
| 2019-09-30 | 3.25M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 3.17M shares 10-Q · filed 2019-08-12 |
| 2019-03-31 | 3.17M shares 10-Q · filed 2019-05-13 |
| 2018-12-31 | 2.13M shares 10-K · filed 2020-03-26 |
| 2018-09-30 | 1.52M shares 10-Q · filed 2018-11-15 |
| 2017-12-31 | 1.19M shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |